ArticleAnnals of surgical oncology2012

A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity.

G M Beasley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.